The Food and Drug Administration’s (FDA) user fee programs, which pay the salaries of agency staff who review drug and medical device applications, are set to expire on October 1, 2022..
Food and Drug Administration FDA user fee programs pay the salaries of agency staff review drug and medical device applications set to expire. Prescription Drug User Fee Act PDUFA, Generic Drug User Fee Amendments GDUFA, Biosimilar User Fee Act BsUFA, Medical Device User Fee Amendments MDUFA.